Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.

PublicSource reached out to more than 30 federally funded researchers in Pittsburgh who have been impacted by the Trump administration's policies. Only five agreed to talk. We detailed their research ...

Clinical trials have been delayed, contracts canceled and support staff fired. With deeper cuts coming, some are warning of ...

PITTSBURGH, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat ...

A deadly hospital superbug has evolved into a global force by weaponizing a genetic tool to wipe out its microbial ...

Head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy ...

Research from the University of Pittsburgh's Swanson School of Engineering ... tools and expand the inclusion criteria for therapeutic drug trials targeting Alzheimer's disease and dementia.

Patients hoping for a kidney transplant must first undergo a battery of medical tests to determine whether they are suitable candidates for the procedure and healthy enough to take post-transplant ...

Scientists have developed a new chemical method that could make it easier, safer and more environmentally friendly to create ...

A new study led by a University of New Mexico Health Sciences researcher demonstrates that a “concierge” approach called the Kidney Transplant Fast Track (KTFT), in which the testing is coordinated ...